RETRACTED ARTICLE: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma

Yue Fan, Lili Xu, Chenye Shi, Wei Wei, Dansong Wang, Ding-Fang CaiScientific 2016 · DOI · OpenAlex

Notice to Readers: This article has been formally retracted by the journal Scientific Reports. The summary below outlines the scientific narrative as originally published, but these findings are no longer considered part of the reliable scientific record.

Introduction

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a poor prognosis. Its progression is heavily influenced by the tumor microenvironment, particularly the recruitment of tumor-associated macrophages (TAMs) that support cancer cell growth and invasion. While the role of hypoxia-inducible factor 1 (HIF-1) in driving PDAC is well-documented, the specific mechanisms controlling macrophage recruitment have remained less clear.

This study focused on stromal cell-derived factor-1 (SDF-1), a potent chemoattractant known to recruit macrophages to tumor sites. A key observation in PDAC patients is that while SDF-1 protein levels are significantly elevated in tumor tissue compared to normal tissue, its mRNA levels do not show a corresponding increase. This discrepancy suggested that a post-transcriptional regulator, likely a microRNA, was failing to suppress SDF-1 production in cancer cells, thereby facilitating an environment conducive to tumor growth.

Methods

The researchers investigated this mechanism through several experimental layers:

  • Clinical Correlation: Analysis of 32 paired PDAC and normal tissue (NT) specimens from Zhongshan Hospital, Fudan University. Researchers used RT-qPCR to measure mRNA levels and ELISA for protein quantification.
  • Molecular Validation: Luciferase reporter assays were employed to confirm direct binding between miR-454 and the 3'-UTR of the SDF-1 gene. By mutating the predicted binding site, they could verify if miR-454 specifically targeted that sequence.
  • Functional Migration Assays: A transwell system was used to measure the movement of bone marrow-derived macrophages toward PANC-1 (pancreatic cancer) cells. The cancer cells were genetically modified to either overexpress or deplete miR-454 to observe changes in macrophage chemoattraction.
  • In Vivo Modeling: Modified PANC-1 cells were implanted into NOD/SCID mice. Over a 30-day period, the researchers tracked tumor volume and used flow cytometry to quantify the infiltration of CD68+ macrophages.

Key Results and Insights

miR-454 as a Post-Transcriptional Regulator

The study identified miR-454 as the "missing link" in SDF-1 regulation. In healthy pancreatic tissue, miR-454 binds to SDF-1 mRNA and inhibits its translation into protein. In PDAC, miR-454 is significantly downregulated, which removes this inhibition and leads to the overproduction of SDF-1 protein. Clinical data showed a strong negative correlation (r = -0.70, p < 0.0001) between miR-454 levels and SDF-1 protein.

Impact on the Tumor Microenvironment

The elevation of SDF-1 acts as a paracrine signal that recruits CD68+ macrophages to the tumor site. In co-culture experiments, macrophages migrated significantly more toward miR-454-depleted cancer cells. Conversely, overexpressing miR-454 in cancer cells significantly reduced macrophage recruitment, suggesting that miR-454 normally acts as a "brake" on this immune cell influx.

Tumor Growth in Mouse Models

The functional consequences were evident in vivo:

  • miR-454 Depletion: Led to significantly faster tumor growth and a higher density of infiltrating macrophages.
  • miR-454 Overexpression: Resulted in significantly slower tumor progression and reduced macrophage presence.

Discussion and Limitations

The authors concluded that miR-454 acts as a tumor suppressor by limiting the SDF-1-mediated recruitment of macrophages. However, they noted several limitations, including the use of a subcutaneous mouse model rather than an orthotopic one, which may not fully capture the complexities of the pancreatic microenvironment. Additionally, the study focused primarily on the PANC-1 cell line and macrophages, whereas the PDAC stroma contains a diverse array of cells, such as mesenchymal cells, that may also interact with the SDF-1 pathway.

Scientific Note: Due to the retraction of the original paper, the data and conclusions presented here should be viewed with extreme caution. Retractions in this field often stem from issues with data integrity or image duplication that undermine the study's reliability.

Summary updated

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant carcinoma with an extremely high lethality. We recently reported that hypoxia-inducible factor 1 (HIF-1) targets quiescin sulfhydryl oxidase 1 to facilitate PDAC cell growth and invasion. Here, we analyzed the control of another HIF-1 target, stromal cell derived factor-1 (SDF-1), in PDAC cells. We detected significantly more CD68+ macrophages in the PDAC, compared to normal human pancreas (NT). Since macrophages are recruited to the tissue through their expression of CXCR4 in response to SDF-1, we thus examined the SDF-1 levels in the PDAC specimens. Surprisingly, the SDF-1 protein but not mRNA significantly increased in PDAC, compared to NT. Moreover, a SDF-1-targeting microRNA, miR-454, was found to decrease in PDAC. Promoter luciferase assay confirmed that bindings of miR-454 to 3'-UTR of SDF-1 mRNAs inhibited SDF-1 protein translation. Co-culture of bone marrow derived macrophages and miR-454-modified PDAC cells in a transwell migration experiment showed that macrophages migrated less towards miR-454-overexpressing PDAC cells, and migrated more towards miR-454-depleted cells. Implanted miR-454-depleted PDAC cells grew significantly faster than control, while implanted miR-454-overexpressing PDAC cells grew significantly slower than control. Together, our data suggest that miR-454 may regulate SDF-1 in the control of the growth of PDAC.
BibTeX
@inproceedings{fan2016retracted,
  author = {Yue Fan and Lili Xu and Chenye Shi and Wei Wei and Dansong Wang and Ding-Fang Cai},
  title = {{RETRACTED ARTICLE: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma}},
  booktitle = {Scientific},
  year = {2016},
  doi = {10.1038/srep22793},
}
Figure